We analysed 12 radical prostatectomy specimens of patients with T1c prostatic cancer in order to evaluate clinical, bioptical and pathological features. Of the tumours, 8/12 (67%) were locally advanced, with Gleason score of 6 or 7. The majority of our stage T1c tumours were significant and required radical treatment.
CatalonaW.J.SmithD.S.RatliffT. L.BaslerJ.W.: Detection of organ confined prostate cancer is increased through prostate specific antigen based screening. Jama, 270: 948, 1993.
2.
BrawerM.K.ChetnerM.P.BeatieJ.BuchkerD.M.VessellaR.L.LangeP.H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
3.
CatalonaW.J.SmithD.S.RatliffT.L.DoddsD.M.CoplenD.E.YuanJ.J.PetrosJ.A.AndrioleG.L.: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324: 1156, 1991.
4.
StormontT.J.FarrowG.M.MyersR.P.BluteM.L.ZinckeH.WilsonT.M.OesterlingJ.E.: Clinical stage BO or T1c prostate cancer: non-palpable disease identified by elevated serum prostate specific antigen concentration. Urology, 41: 3, 1993.
5.
EpsteinJ.I.WalshP.C.CarmichaelM.J.BrendlerC.B.: Pathological and clinical findings to predict tumour extent of non-palpable (stage T1c) prostate cancer. Jama, 271: 368, 1994.
6.
OerterlingJ.E.SumanV.J.ZinckeH.BostwickD.G.: PSA detected (clinical stage T1c or BO) prostate cancer. Pathologically significant tumours. Urol. Clin. North Am., 20–4:687, 1993.
7.
Ballentine CarterH.SauvegeotJ.WalshP.C.EpsteinJ.I.: Postoperative evaluation of men with stage T1c adenocarcinoma of the prostate. J. Urol., 157: 2206, 1997.
8.
ElgamalA.A.Van PoppelH.P.Van de VoordeW.M.Van DorpeJ.A.OyenR.H.BaertL.V.: Impalpable, invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens. A different view. J. Urol., 157: 244, 1997.
9.
ScaletsckyR.KochO.EcksteinC.Lane BicknellS.GrayG.SmithJ.: Tumour volume and stage in carcinoma of prostate detected by elevations in prostate specific antigen. J. Urol., 152: 129, 1994.
10.
LernerS.SeayT.BluteM.BergstralhE.BarrettD.ZinckeH.: Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J. Urol., 155: 821, 1996.
